HIV Tat/delta-V2 Env vaccine (Istituto Superiore di Sanita/Novartis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV Tat/delta-V2 Env vaccine (Istituto Superiore di Sanita/Novartis)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine +[4]

Mechanisms of ActionHIV envelope protein gp120 modulatorsHuman Immunodeficiency Virus tat Gene Products modulators

TargetsHuman Immunodeficiency Virus tat Gene ProductsHIV envelope protein gp120

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIstituto Superiore Di Sanita

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Vaccines And Diagnostics Inc Istituto Superiore Di Sanita

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A